Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor × Latent Class Analysis × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

senaparib 6 Irinotecan 6 pembrolizumab 5 Paclitaxel 5 Docetaxel 5 Cisplatin 5 Capecitabine 5 Fluorouracil 4 Rifampin 3 Midazolam 3 Leucovorin 3 Itraconazole 3 Injections 3 Bevacizumab 3 pertuzumab 2 atezolizumab 2 Nivolumab 2 Gemcitabine 2 vofatamab 1 tremelimumab 1 trastuzumab duocarmazine 1 talazoparib 1 sotorasib 1 saracatinib 1 ridaforolimus 1 regorafenib 1 prexasertib 1 pexidartinib 1 pemigatinib 1 pamiparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡